BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27644318)

  • 21. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples.
    Lu BY; Thanawala SU; Zochowski KC; Burke MJ; Carroll WL; Bhatla T
    Leuk Lymphoma; 2016 Aug; 57(8):1938-41. PubMed ID: 26726842
    [No Abstract]   [Full Text] [Related]  

  • 22. Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Ricci F; Tazzari P; Chiarini F; Battistelli M; Falcieri E; Ognibene A; Pagliaro P; Cocco L; McCubrey JA; Martelli AM
    J Cell Physiol; 2011 Mar; 226(3):822-31. PubMed ID: 20857426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
    Gong H; Liu L; Cui L; Ma H; Shen L
    Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
    Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
    BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
    Yang T; Yao S; Zhang X; Guo Y
    Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Hormones in the Regulation of RACK1 Expression as a Signaling Checkpoint in Immunosenescence.
    Racchi M; Buoso E; Ronfani M; Serafini MM; Galasso M; Lanni C; Corsini E
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28684670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RACK1/TRAF2 regulation of modulator of apoptosis-1 (MOAP-1).
    Law J; Kwek I; Svystun O; Lim J; Tan CT; Luong L; Yu VC; Baksh S
    Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):684-694. PubMed ID: 29470995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
    Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
    Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines.
    Liu S; Breit S; Danckwardt S; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2009 Jul; 88(7):613-21. PubMed ID: 19057901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.
    Chu M; Yin K; Dong Y; Wang P; Xue Y; Zhou P; Wang Y; Wang Y
    Oncotarget; 2017 Jan; 8(1):1405-1415. PubMed ID: 27902457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.
    Zadi Heydarabad M; Nikasa M; Vatanmakanian M; Azimi A; Farshdousti Hagh M
    J Cell Biochem; 2018 Jun; 119(6):4890-4896. PubMed ID: 29377275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA; Kwock R; Avramis VI
    Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling.
    Liu X; Liu S; Chen J; He L; Meng X; Liu S
    Ann Hematol; 2016 Oct; 95(11):1787-93. PubMed ID: 27506924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
    Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of HSP27 in RACK1-mediated PKC activation in THP-1 cells.
    Corsini E; Galbiati V; Papale A; Kummer E; Pinto A; Guaita A; Racchi M
    Immunol Res; 2016 Aug; 64(4):940-50. PubMed ID: 27178349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.
    Schult C; Dahlhaus M; Glass A; Fischer K; Lange S; Freund M; Junghanss C
    Anticancer Res; 2012 Feb; 32(2):463-74. PubMed ID: 22287733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.